Now Available:
Download the podcast of Dr. Cohen's video presentation

CME Opportunity:

International Society of Extremity MRI in Rheumatology Conference:
Chicago, April 10, 2008

Musculoskeletal Report provides cutting-edge scientific updates through in-depth interviews, on-location coverage of medical meetings, expert-led panel discussions, and live newscasts. With biweekly and special edition newsletters, MSK Report is the top online resource for staying abreast of the most current and clinically relevant information in the field of musculoskeletal disease and treatment.

Consumer News: Learn what your patients are reading in the popular press

Tysabri May Cause Liver Damage, Health Officials Say
Tysabri, the MS drug recently approved for treatment of Crohn's disease, can cause liver damage in as few as 6 days...

New from PubMed: Keep up-to-date with what is on PubMed

Anti-Tumor Necrosis Factor-α Therapy and Potential Cancer Inhibition
Anti-TNF-α therapy may reduce the risk of neoplasia in patients being treated for chronic inflammation...

MSK Video Report:
New Treatment Developments
Dr. Marc Cohen presents new drugs and treatment options for RA in the final installment of our 4-part series, "RA and Infusion Therapy"...

Autoimmunity: Adult Stem Cells Nearing Clinical Use for RA, SLE, Other Autoimmune Diseases
Adult stem cells offer a safer, less controversial approach than embryonic stem cells to treat various rheumatoid and autoimmune diseases, and are now entering randomized clinical trials...

Pain: Regular Aquatic Exercise Could Benefit Fibromyalgia Sufferers
Adding aquatic exercise 3 times a week to usual care for fibromyalgia may be a cost-effective strategy for improving quality of life...

BioPharm Business: Acceleron, Celgene to Collaborate on Anabolic Bone Agent ACE-011, a Decoy Activin Receptor, for Cancer-Related Bone Loss
Acceleron Pharma and Celgene Corp announced a worldwide strategic collaboration for the development and commercialization of ACE-011, a novel bone-forming compound for the treatment of cancer-related bone loss...

To remove your e-mail address from our mailing list, please reply to this e-mail with "unsubscribe" in the subject line. For questions and comments regarding this newsletter please contact .